Curity Pharma announces that it has received the official operating license from the competent regulatory authorities of the Ministries of Development, Health, and Rural Development and Food. This approval marks a milestone for the company, as it allows for the immediate commencement of full operations at its vertically integrated production facility, which will develop advanced pharmaceutical solutions that meet the modern needs of patients.

The new unit of Curity Pharma is fully equipped with cutting-edge technology, ensuring high standards of quality, safety, and compliance with European regulations. Curity Pharma has invested in staffing a specialized team of scientists, skilled technicians, researchers, and industry executives, aiming to meet the increasing demands of the European market. The workforce and co-founders of the company are consistently and dedicatedly working towards their vision of providing innovative and reliable products to meet patient needs and offer solutions to health sector professionals.